APAC Region

Since 2011, DiagnoSearch has established a strong presence across the Asia-Pacific region, starting with South Korea and expanding into Thailand, the Philippines, Malaysia, Australia and New Zealand.

Clinical Operations Services APAC

The APAC region is a hub for large, multi-center Phase II and Phase III trials, where timelines, patient diversity, and regulatory navigation are critical. Our success here is built on

  • Deep regional knowledge and trusted investigator networks.
  • Seamless compliance with evolving APAC regulatory frameworks.
  • Proven ability to deliver clinical operations services APAC with speed and precision.

By combining global oversight with local agility, DiagnoSearch ensures that sponsors can confidently advance development programs in Southeast Asia and beyond.

India
India

DiagnoSearch began operations in India in 1995 as a one of the first central laboratories dedicated to clinical trials in India. Responding to Industry demand for clinical research services, DiagnoSearch evolved to become one of the first home grown CROs in the country.

For the past 30+ years, we have served 65+ clients across all functional areas and most therapeutic areas and phases, leveraging our Indian operations.

What we bring to India

  • End-to-end support for clinical trials across therapeutic areas and phases of development
  • A stable team across functions and one of the highest retention rates for functional expertise in the industry
  • Strategic investments in technology to deliver better value to clients
  • 300+ programs across the globe supported from India including some of the largest clinical trials in India
  • Relationships with clinical trial sites across the length and breadth of India
  • 100,000+ participants recruited in India
  • Audited 300+ times by clients / independent auditors
Bangladesh
Bangladesh

Pioneering High-Volume Vaccine Trials

In Bangladesh, DiagnoSearch is one of the few CROs with in-country site monitors, ensuring continuous oversight and reliable execution. Our partnerships with leading institutes have enabled the enrollment of thousands of participants in high-volume vaccine trials.

Our Bangladesh portfolio includes pivotal Phase III vaccine studies, such as the Oral Polio Vaccine and Hexavalent Vaccine trials. In this region, where preventive medicine and vaccine development are at the forefront, our expertise ensures successful trial delivery through

  • End-to-end clinical operations support.
  • Local oversight paired with global-quality standards.
  • Integration with India-based teams for Clinical Data Management services, Biostatistics, QA, and Medical Services.

Bangladesh is an emerging center for vaccine research, and DiagnoSearch continues to play a pioneering role in shaping its clinical research ecosystem.

Australia/NZ
Australia & New Zealand

DiagnoSearch began supporting clinical trials in Australia in 2015 and in New Zealand in 2025, thereby expanding our footprint in APAC

A brief timeline of our operations

  • Initiated the first study in Australia in 2015–16 for an oncology product
  • Supported COVID-19 vaccine studies in Australia – electronic systems set-up in record time for 3 clinical trials
  • Data Management, Biostatistics and Medical Writing support provided from India for multiple clinical trials conducted in Australia

What we bring to Australia & New Zealand

  • End-to-end clinical operations support
  • Robust site relationships for fast paced recruitment
  • Seamless coordination with India-based experts